
Pharma’s New Marketing Imperative: The Agentic Shift
The life science industry is at a critical inflection point. Driven by the twin forces of personalized medicine and an explosion of real-world data, the demand for innovative, patient-centric engagement has never been higher. Yet, pharmaceutical marketing remains trapped in a complex ecosystem: channels are fragmented, regulatory review cycles are lengthy, and success hinges on simultaneously influencing three distinct stakeholders – patients, prescribers (HCPs), and payers.
Share this report





